Interní Med. 2009; 11(5): 211-214

Sudden cardiac death

MUDr. Milan Kozák Ph.D
Interní kardiologická klinika FN a LF MU v Brně

More than 2.500 persons from European population die of sudden cardiac death every day. Nearly 90 % of these cases are caused by

malignant ventricular arrhythmias, which develope most frequently on the basement of structural heart disease. Some subpopulations

of patients can be marked as a high risk for sudden cardiac death according to the today stratification procedures and can be treated

in a pharmacological or nonpharmacological ways. The ways are as follows: a chronic therapy with betablockers agents, therapy of

congestive heart failure, myocardial revascularisation and implantation of cardioverter-defibrillator. The prognosis of patients treated

in those ways in comparison with conservatively treated groups is very good.

Keywords: sudden cardiac death, defibrillation, implantable cardioverter-defibrillator.

Published: June 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kozák M. Sudden cardiac death. Interní Med. 2009;11(5):211-214.
Download citation

References

  1. Zheng ZJ, Croft J, Wayne HG, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104: 2158-2163. Go to original source... Go to PubMed...
  2. Eisenberg MS, Cummins RO, Damon S, Larsen MP, Hearne TP. Survival rate from out-of-hospital cardiac arrest: recommendation for uniform definitions and data to report. Ann Emerg Med 1990; 19: 1249-1259. Go to original source... Go to PubMed...
  3. Gillum RF. Sudden coronary death in the United States, 1980-1985. Circulation 1989; 79: 756-765. Go to original source... Go to PubMed...
  4. Pisa Z. Sudden death: a worldwide problem. In: Kulbertus H, Wellens HJJ (eds). Sudden Death. The Hague, The Netherlands: Martinus Nijhoff; 1980: 3-10. Go to original source...
  5. Taylor AJ, Burke AP, O´Malley PG. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation 2000; 101: 1243-1246. Go to original source... Go to PubMed...
  6. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. A Engl J Med 2001; 345 (20): 1473-1483. Go to original source... Go to PubMed...
  7. Hallstrom AP, Eisenberg MS, Bergner L. The persistence of ventricular fibrillation and its implication for evaluating EMS. Emerg Health Serv Q 1983; 1: 41-47. Go to original source... Go to PubMed...
  8. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: The Paris Prospective Study I. Circulation 1999; 99: 1978-1983. Go to original source... Go to PubMed...
  9. Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001; 12: 369-381. Go to original source... Go to PubMed...
  10. Huikuri HV, Tapanainen JM, Lindgren K, et al. Prediction of sudden cardiac death after myocardial infarction in the betablocking era. J Am Coll Cardiol; 2003, 42 (4): 652-658. Go to original source... Go to PubMed...
  11. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: Structure, function, and time-dependence of risk. Circulation 1992; 85 (S1): 1-2. Go to PubMed...
  12. Wilkerson group survey: Congestive heart failure worldwide markets, clinical status and product development opportunities. New Medicine, Inc. 1997; 1-40.
  13. Kearney MT, Fox KAA, Brooksby WP, et al. Predicting sudden death in patients with mild to moderate chronic heart failure. Heart 2004; 90: 1137-1143. Go to original source... Go to PubMed...
  14. Křivan L, Kozák M, Sepši M, et al. Využití turbulence srdečního rytmu v rizikové stratifikaci nemocných po prodělaném infarktu myokardu. Cardiol 2005; 15 (5): 219-224.
  15. Křivan L. Náhlá srdeční smrt, jak jí předcházet. Kardiol Rev 2006; 8: 20-24.
  16. Hoffa M, Ludwig C. Einige neue Versuche uber Herzbewegung. Zeitschrift Rationelle Medizin, 1850; 9: 107-144.
  17. Beck CS, Pritchard WH, Feil HS. Ventricular fibrillation of long duration abolished by electric shock. Jour. Amer. Med. Assoc. 1947; 135: 985. Go to original source... Go to PubMed...
  18. Willoughby PJ, Caffrey S. Improved survival with an airport based PAD program. Circulation 2000; 102: II-828.
  19. Stiell IG, Wells GA, Field BJ, et al. Improved out-of-hospital cardiac arrest survival through the inexpensive optimalization of an existing defibrillation program: OPALS Study Phase II. JAMA. 1999; 281: 1175-1181. Go to original source... Go to PubMed...
  20. Kellermann AL, Hackman BB, Somes G, et al. Impact of first-responder defibrillation in an urban medical services system. JAMA. 1993; 270: 1708-1713. Go to original source...
  21. Weaver W, Hill D, Fahrenbruch CE, et al. Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest. A Engl J Med. 1988; 319: 661-666. Go to original source... Go to PubMed...
  22. Eisenberg MS, Hallstrom AP, Copass MK, et al. Treatment of ventricular fibrillation: emergency medical technician defibrillation and paramedic services. JAMA. 1984; 251: 1723-1726. Go to original source... Go to PubMed...
  23. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303: 322-324. Go to original source... Go to PubMed...
  24. Křivan L, Sepši M, Semrád B. Péče o nemocné s implantabilními kardiovertery-defibrilátory: Co by měl vědět každý lékař. Vnitř. Lék. 2004; 50: 54-60.
  25. Camm JA, Luscher TF, Serruys PW. Sudden cardiac death and Resuscitation in The ESC Textbook of Cardiovascular Medicine. Blackwell Publishing, Oxford UK, 2006; cap 33: 973-991.
  26. Denton TA, Diamond GA, Helfant RH, et al. Fascinating rhythm: a primer on chaos theory and its application to cardiology. Am Heart J 1990; 120: 1419-1440. Go to original source... Go to PubMed...
  27. Weiss JN, Garfinkel A, Karagueuzian HS, et al. Chaos and transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation. Circulation 1999; 99: 2819-2826. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.